HEADER IMMUNE SYSTEM 10-JUN-09 2KJU TITLE NMR STRUCTURE OF HUMAN INSULIN MUTANT GLU-B21-D-GLU, HIS-B10 ASP PRO- TITLE 2 B28-LYS, LYS-B29-PRO, 20 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: INSULIN A CHAIN, RESIDUES 90-110; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: INSULIN B CHAIN, RESIDUES 25-54; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: INS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBR322; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: INS; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PBR322 KEYWDS HORMONE, HUMAN INSULIN, MUTANT, FIBRILLATION, STABILITY, CARBOHYDRATE KEYWDS 2 METABOLISM, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, KEYWDS 3 GLUCOSE METABOLISM, SECRETED, DIABETES MELLITUS, DISEASE MUTATION, KEYWDS 4 PHARMACEUTICAL, IMMUNE SYSTEM EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Q.X.HUA,K.HUANG,S.Q.HU,P.KATSOYANNI,M.A.WEISS REVDAT 2 13-OCT-21 2KJU 1 REMARK SEQADV LINK REVDAT 1 16-JUN-10 2KJU 0 JRNL AUTH Q.X.HUA,K.HUANG,S.Q.HU,P.KATSOYANNI,M.A.WEISS JRNL TITL ACCELERATION OF PROTEIN FIBRILLATION BY CHIRAL JRNL TITL 2 DESTABILIZATION OF BETA-TURN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.85 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RMSD VALUES FOR ALL 20 STRUCTURES REMARK 3 VERSUS GEOMETRIC AVERAGE: (BACKBONE, A2-A20, B4-B24) 0.42 REMARK 3 ANGSTROM REMARK 4 REMARK 4 2KJU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1000101209. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298; 305 REMARK 210 PH : 7.0; 2.0; 7.6 REMARK 210 IONIC STRENGTH : 0.1; 0.1; 0.1 REMARK 210 PRESSURE : 1 BAR; 1 BAR; 1 BAR REMARK 210 SAMPLE CONTENTS : 0.5 MM INSULIN A CHAIN, 0.5 MM REMARK 210 INSULIN B CHAIN, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY; NOESY; COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.5 REMARK 210 METHOD USED : DISTANCE GEOMETRY AND SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 40 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR NMR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 INSULIN B-CHAIN MADE VIA SEMI-SYNTHESIS: EXPRESSED INSULIN B-CHAIN REMARK 400 WAS DIGEST THEN MERGED WITH ORGANIC SYNTHESIZED PART OF B-CHAIN REMARK 400 (CONTAINED B21-D-GLU). REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER B 9 H GLU B 13 1.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 VAL A 3 -80.82 -64.16 REMARK 500 1 CYS A 11 -147.07 -100.06 REMARK 500 1 ARG B 22 26.78 43.42 REMARK 500 1 PHE B 25 59.46 -113.83 REMARK 500 1 LYS B 28 90.09 -178.47 REMARK 500 2 ILE A 2 -52.71 -134.96 REMARK 500 2 VAL A 3 -79.22 -52.63 REMARK 500 2 SER A 9 -158.39 -167.44 REMARK 500 2 CYS A 20 104.18 -47.37 REMARK 500 2 GLN B 4 -151.54 -135.79 REMARK 500 2 PHE B 24 -171.49 176.79 REMARK 500 2 PHE B 25 -74.92 -110.78 REMARK 500 2 TYR B 26 108.69 55.72 REMARK 500 3 VAL A 3 -80.43 -53.74 REMARK 500 3 CYS A 20 104.65 -44.89 REMARK 500 3 ASN B 3 100.38 -49.27 REMARK 500 3 CYS B 7 154.32 175.72 REMARK 500 3 DGL B 21 -48.72 80.37 REMARK 500 3 ARG B 22 -83.57 -43.78 REMARK 500 3 PHE B 24 -170.23 177.07 REMARK 500 3 LYS B 28 90.32 173.66 REMARK 500 4 VAL A 3 -79.75 -77.69 REMARK 500 4 SER A 9 -156.59 178.33 REMARK 500 4 CYS A 20 105.75 -43.11 REMARK 500 4 ASN B 3 93.11 -66.09 REMARK 500 4 ARG B 22 -93.40 -98.35 REMARK 500 4 PHE B 24 -168.79 -175.48 REMARK 500 4 LYS B 28 81.12 45.02 REMARK 500 5 VAL A 3 -82.59 -42.43 REMARK 500 5 SER A 9 -154.88 -167.45 REMARK 500 5 ARG B 22 30.62 34.98 REMARK 500 5 PHE B 24 123.37 179.36 REMARK 500 6 ILE A 2 -32.43 -132.93 REMARK 500 6 VAL A 3 -74.05 -61.08 REMARK 500 6 ASN B 3 100.92 -54.91 REMARK 500 6 DGL B 21 -147.95 170.33 REMARK 500 6 PHE B 25 -80.93 -99.49 REMARK 500 6 TYR B 26 95.25 45.21 REMARK 500 7 VAL A 3 -79.85 -48.15 REMARK 500 7 CYS A 11 -167.54 -110.12 REMARK 500 7 CYS A 20 107.19 -42.95 REMARK 500 7 ASN B 3 60.59 -159.49 REMARK 500 7 GLN B 4 -152.82 -125.00 REMARK 500 7 DGL B 21 -114.66 170.29 REMARK 500 7 ARG B 22 15.62 -149.94 REMARK 500 7 PHE B 24 -172.58 -173.58 REMARK 500 7 THR B 27 -151.03 -127.83 REMARK 500 7 LYS B 28 89.57 -154.22 REMARK 500 8 CYS A 20 107.61 -44.82 REMARK 500 8 DGL B 21 -131.40 170.03 REMARK 500 REMARK 500 THIS ENTRY HAS 135 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG B 22 0.22 SIDE CHAIN REMARK 500 2 ARG B 22 0.21 SIDE CHAIN REMARK 500 3 ARG B 22 0.25 SIDE CHAIN REMARK 500 4 ARG B 22 0.31 SIDE CHAIN REMARK 500 5 ARG B 22 0.10 SIDE CHAIN REMARK 500 6 ARG B 22 0.28 SIDE CHAIN REMARK 500 7 ARG B 22 0.20 SIDE CHAIN REMARK 500 8 ARG B 22 0.32 SIDE CHAIN REMARK 500 9 ARG B 22 0.16 SIDE CHAIN REMARK 500 10 ARG B 22 0.27 SIDE CHAIN REMARK 500 11 ARG B 22 0.31 SIDE CHAIN REMARK 500 12 ARG B 22 0.27 SIDE CHAIN REMARK 500 13 ARG B 22 0.22 SIDE CHAIN REMARK 500 14 ARG B 22 0.32 SIDE CHAIN REMARK 500 15 ARG B 22 0.21 SIDE CHAIN REMARK 500 16 ARG B 22 0.32 SIDE CHAIN REMARK 500 17 ARG B 22 0.29 SIDE CHAIN REMARK 500 18 ARG B 22 0.28 SIDE CHAIN REMARK 500 19 ARG B 22 0.23 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 16343 RELATED DB: BMRB REMARK 900 RELATED ID: 2KJJ RELATED DB: PDB DBREF 2KJU A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2KJU B 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 2KJU ASP B 10 UNP P01308 HIS 34 ENGINEERED MUTATION SEQADV 2KJU DGL B 21 UNP P01308 GLU 45 ENGINEERED MUTATION SEQADV 2KJU LYS B 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 2KJU PRO B 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER ASP LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY DGL ARG GLY PHE PHE TYR SEQRES 3 B 30 THR LYS PRO THR HET DGL B 21 15 HETNAM DGL D-GLUTAMIC ACID FORMUL 2 DGL C5 H9 N O4 HELIX 1 1 GLY A 1 THR A 8 1 8 HELIX 2 2 SER A 12 ASN A 18 1 7 HELIX 3 3 GLY B 8 GLY B 20 1 13 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.02 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.02 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.02 LINK C GLY B 20 N DGL B 21 1555 1555 1.31 LINK C DGL B 21 N ARG B 22 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15 MODEL 16 MODEL 17 MODEL 18 MODEL 19 MODEL 20